城建發展(600266.SH)聯合體22.4億元競得土地使用權
格隆匯5月28日丨城建發展(600266.SH)公佈,2021年5月27日公司收到《北京市國有建設用地使用權掛牌出讓成交確認書》,公司與北京迪多納企業管理有限公司組成的聯合體以22.4億元的價格競得北京城市副中心0302街區FZX-0302-6004、6002地塊F1住宅混合公建用地、A334托幼用地國有建設用地使用權,公司與北京迪多納企業管理有限公司的投資比例為49%:51%。
項目位於通州區梨園鎮,FZX-0302-6004、6002地塊用地性質為F1住宅混合公建用地、A334托幼用地,總建設用地規模約4.45萬平方米,規劃地上建築規模約9.59萬平方米,政府持有商品住宅產權份額為20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.